Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 5 months ago
Share
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
292 patients around the world
Available in
Chile, Argentina, Mexico, United States
GlaxoSmithKline
292
Patients around the world
This study is for people with
Asthma
Requirements for the patient
To 17 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Sponsor
GlaxoSmithKline
Conditions
Requirements
To 17 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05757102
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent